Kava-kava and anxiety: growing knowledge about the efficacy and safety (Q34880255)

5 August 2017

1 reference

title

Kava-kava and anxiety: growing knowledge about the efficacy and safety (English)

1 reference

5 August 2017

Anna Rita Bilia

1

1 reference

5 August 2017

Sandra Gallon

series ordinal

2

1 reference

5 August 2017

Franco F Vincieri

series ordinal

3

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

5 August 2017

1 reference

5 August 2017

70

1 reference

5 August 2017

2581-2597

1 reference

5 August 2017

22

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

5 August 2017

1 reference

Pharmacopsychological effects of oxazepam and kava-extract in a visual search paradigm assessed with event-related potentials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Effects of oxazepam and an extract of kava roots (Piper methysticum) on event-related potentials in a word recognition task.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Necrotizing hepatitis after taking herbal remedies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Hepatitis associated with Kava, a herbal remedy for anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Electrospray high performance liquid chromatography-mass spectrometry in phytochemical analysis of kava (Piper methysticum) extract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Identification by methane chemical ionization gas chromatography/mass spectrometry of the products obtained by steam distillation and aqueous acid extraction of commercial Piper methysticum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Kava pyrones and resin: studies on GABAA, GABAB and benzodiazepine binding sites in rodent brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Influence of genuine kavapyrone enantiomers on the GABA-A binding site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

[3H]-monoamine uptake inhibition properties of kava pyrones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Kavain inhibits non-stereospecifically veratridine-activated Na+ channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

(+/-)-Kavain inhibits veratridine-activated voltage-dependent Na(+)-channels in synaptosomes prepared from rat cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Effects of (+/-)-kavain on voltage-activated inward currents of dorsal root ganglion cells from neonatal rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Kava extract ingredients, (+)-methysticin and (+/-)-kavain inhibit voltage-operated Na(+)-channels in rat CA1 hippocampal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

The protective action of tetrodotoxin and (+/-)-kavain on anaerobic glycolysis, ATP content and intracellular Na+ and Ca2+ of anoxic brain vesicles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

(+/-)-kavain inhibits the veratridine- and KCl-induced increase in intracellular Ca2+ and glutamate-release of rat cerebrocortical synaptosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Anticonvulsive action of (+/-)-kavain estimated from its properties on stimulated synaptosomes and Na+ channel receptor sites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Relaxation of evoked contractile activity of isolated guinea-pig ileum by (+/-)-kavain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

The influence of (+/-)-kavain on population spikes and long-term potentiation in guinea pig hippocampal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Effects of kawain and dihydromethysticin on field potential changes in the hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Preliminary Characterization of Aqueous Extracts of Piper methysticum (Kava, Kawa Kawa)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

CENTRAL ACTIVITY OF AQUEOUS EXTRACTS OF PIPER METHYSTICUM (KAVA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Effect of kava extract and individual kavapyrones on neurotransmitter levels in the nucleus accumbens of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

In vivo effects of the kavapyrones (+)-dihydromethysticin and (+/-)-kavain on dopamine, 3,4-dihydroxyphenylacetic acid, serotonin and 5-hydroxyindoleacetic acid levels in striatal and cortical brain regions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Strychnine antagonistic potency of pyrone compounds of the kavaroot (Piper methysticum Forst.).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

A chemical and pharmacological investigation of Piper methysticum Forst

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

In vivo microdialysis study of (+/-)-kavain on veratridine-induced glutamate release.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

The quantitative EEG as a screening instrument to identify sedative effects of single doses of plant extracts in comparison with diazepam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Efficacy of a special Kava extract (Piper methysticum) in patients with states of anxiety, tension and excitedness of non-mental origin - A double-blind placebo-controlled study of four weeks treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Efficacy of kava extract for treating anxiety: systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Antithrombotic action of the kava pyrone (+)-kavain prepared from Piper methysticum on human platelets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Kava and dopamine antagonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Positive interaction of ethanol and kava resin in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

Effects of the heavy usage of kava on physical health: summary of a pilot survey in an Aboriginal community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901555-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0024-3205(02)01555-2

1 reference

5 August 2017

1 reference